Damages in the pharmaceutical and biotech sector
In the April–June 2015 edition of Corporate Disputes, Dr. Gregory Bell and Professor Iain Cockburn discuss damages in the pharmaceutical and biotech sector ....
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Dr. Iain M. Cockburn is an econometrician and industrial organization economist specializing in the pharmaceutical, biotechnology, and health care industries.
His research interests include the economics of innovation, intellectual property, pharmacoeconomics, productivity measurement, competitive strategy, and applied econometrics. He is Professor of Finance and Economics and Richard C. Shipley Professor in Management at the School of Management at Boston University in Boston, MA and a research associate at the National Bureau of Economic Research in Cambridge, MA.
Dr. Cockburn currently serves on the Government Industry Partnerships for the Development of New Technologies, National Research Council, Steering Committee in Washington, DC. He has testified in cases in the US and Canada.
Prior to coming to Boston University, he was the Van Dusen Professor of Business Administration in the Faculty of Commerce the University of British Columbia.
Dr. Cockburn’s research in economics and management is published widely in leading journals, including the Strategic Management Journal, American Economic Review, RAND Journal of Economics, Health Affairs, and the Journal of Industrial Economics. He is currently Co-editor of the Journal of Economics and Management Strategy and was Associate Editor of Management Science.